We are Sorry, This Page doesn't Exist

Shares of Ionis Pharmaceuticals Inc. were down 19.6% in premarket trading on Tuesday, the day after the company said Roche Holding AG decided to discontinue.....»»

Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»

Amgen Inc on Thursday reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus......»»

Amgen Inc on Thursday reported better-than-expected first-quarter results on Thursday and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus......»»

vTv Therapeutics (NSDQ:VTVT), the High Point biopharmaceutical company, expects to complete Phase 2 of its Alzheimer’s disease study by 2021.  The clinical trial for azeliragon, a drug created by the company to slow or halt the progression of t.....»»

Reata Pharmaceuticals Inc. shares were halted in the extended session Monday as the biotech drug developer reported positive results from a late-stage kidney disease treatment study. Reata shares were flat, following a .....»»

Shares of Celgene Corp. [s:celg] rose 0.34% in afternoon trading after the U.S. Food and Drug Administration approved Reblozyl. The drug, which treats anemia in patients with beta thalassemia, a rare blood disorder, was developed jointl.....»»

Micro-cap Intec Pharma Ltd (NASDAQ: NTEC) shares are plummeting on heavy volume Monday following a clinical trial readout from the company.....»»

Cara (CARA) reports positive top-line data from phase III study of Korsuva injection in hemodialysis patients with moderate-to-severe chronic kidney disease-related pruritus. Want th.....»»

The South San Francisco company says its mid-stage study was one of the best for people with ALS; investors initially were skeptical......»»

Lilly's (LLY) cancer drug, Cyramza, in combination with erlotinib significantly delays disease progression in a phase III study on previously untreated patien.....»»

Shares of Biogen Inc (NASDAQ: BIIB) soared higher by more than 13 percent early Friday morning in reaction to the results of an Alzheimer's disease study.  read more.....»»

Celgene Corp. and Acceleron Pharma Inc. sh.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

REDHILL BIOPHAR/S ADR (NASDAQ: RDHL) achieved positive top-line results in its Phase 3 study of RHB-104 in Crohn’s disease, according to a Monday press release. read more.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

AstraZeneca plc (NYSE: AZN) was saved from heartache after its heart disease drug Brilinta succeeded in a late-stage study, sending its shares higher Monday. read more.....»»

New data from Phase 1/2 study of GTX-102 for Angelman syndrome shows rapid and sustained improvement in patients, exceeding natural history data. read more.....»»

On March 14, 2024, Atrium Health Wake Forest Baptist became the first health system in the region to treat a patient with lecanemab, a new medication for Alzheimer’s disease. This is the first Alzheimer’s drug approved by the FDA in more than 20 .....»»

CDC Study Doesn't 'Debunk' Link Between COVID-19 Vaccines & Sudden-Deaths Authored by Zachary Stieber via The Epoch Times, A new U.S. Centers for Disease Control and Prevention (CDC) st.....»»